Cargando…

Adverse Outcomes and Economic Burden of Congenital Adrenal Hyperplasia Late Diagnosis in the Newborn Screening Absence

OBJECTIVE: To establish short- and long-term adverse outcome frequencies related to a late diagnosis of congenital adrenal hyperplasia (CAH) in the absence of newborn screening (NBS) and to determine respective treatment costs, which have never been reported. DESIGN: A retrospective analysis of a CA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miranda, Mirela Costa De, Haddad, Luciana Bertocco de Paiva, Madureira, Guiomar, de Mendonca, Berenice Bilharinho, Bachega, Tania A S S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003980/ https://www.ncbi.nlm.nih.gov/pubmed/32047870 http://dx.doi.org/10.1210/jendso/bvz013

Ejemplares similares

The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts
por: de Miranda, Mirela Costa, et al.
Publicado: (2021)

SUN-361 Reproductive Outcomes in Females with Virilizing Forms of Congenital Adrenal Hyperplasia
por: Falcao, Camila, et al.
Publicado: (2019)

SUN-071 Prenatal and Post-Natal Influence of Androgens in the Psychosexual Development in Individuals with 21-hydroxylase Congenital Adrenal Hyperplasia
por: Batista, Rafael Loch, et al.
Publicado: (2020)

Effects of Pre and Post-Natal Androgen Exposure on Psychosexual Aspects and Gender Change in Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency
por: Batista, Rafael Loch, et al.
Publicado: (2021)

SUN-172 A False Positive Result in Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in a Girl with Beckwith Wiedemann Syndrome
por: Braga, Barbara Leitao, et al.
Publicado: (2020)

Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Gomes, Larissa G., et al.
Publicado: (2013)

Surgical Treatment after Failed Primary Correction of Urogenital Sinus in Female Patients with Virilizing Congenital Adrenal Hyperplasia: Are Good Results Possible?
por: Sircili, Maria Helena Palma, et al.
Publicado: (2016)

Influence of the A3669G Glucocorticoid Receptor Gene Polymorphism on the Metabolic Profile of Pediatric Patients with Congenital Adrenal Hyperplasia
por: Moreira, Ricardo P. P., et al.
Publicado: (2014)

RF21 | PSAT93 Improvement of Final Height in Congenital Adrenal Hyperplasia Patients Treated With Recombinant Growth Hormone
por: Costa, Fernanda C, et al.
Publicado: (2022)

Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia
por: Lousada, Lia Mesquita, et al.
Publicado: (2021)

PSAT072 Clinical Features of Patients with 21-Hydroxylase Deficiency and Testicular Adrenal Rest Tumors
por: Bachega, Tânia A S S, et al.
Publicado: (2022)

SUN-359 Preserved Bone Mineral Density In Adults With Classical Forms Of Congenital Adrenal Hyperplasia Submitted To Long-term Low Glucocorticoid Doses
por: Iervolino, Luiz, et al.
Publicado: (2019)

Corrigendum for “Adverse Outcomes and Economic Burden of Congenital Adrenal Hyperplasia Late Diagnosis in the Newborn Screening Absence”
Publicado: (2021)

Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Moreira, Ricardo P. P., et al.
Publicado: (2011)

Impact of Long-Term Dexamethasone Therapy on the Metabolic Profile of Patients With 21-Hydroxylase Deficiency
por: Seraphim, Carlos E, et al.
Publicado: (2019)

Long-term follow-up of a female with congenital adrenal hyperplasia due to P450-oxidoreductase deficiency
por: Bonamichi, Beatriz D. S. F., et al.
Publicado: (2016)

Increased expression of ACTH (MC2R) and androgen (AR) receptors in giant bilateral myelolipomas from patients with congenital adrenal hyperplasia
por: Almeida, Madson Q, et al.
Publicado: (2014)

Effect of Acute and Chronic Oral Zinc Administration in Hyperprolactinemic Patients
por: Madureira, Guiomar, et al.
Publicado: (1999)

Late diagnosis of classic congenital adrenal hyperplasia: long-term consequences during adulthood
por: Aveiro-Lavrador, Mariana, et al.
Publicado: (2021)

The Presence of Clitoromegaly in the Nonclassical Form of 21-Hydroxylase Deficiency Could Be Partially Modulated by the CAG Polymorphic Tract of the Androgen Receptor Gene
por: Moura-Massari, Vivian Oliveira, et al.
Publicado: (2016)

Mutation distributions among patients with congenital adrenal hyperplasia from five regions of Brazil: a systematic review
por: Hosomi, Silvério S., et al.
Publicado: (2023)

Newborn screening for congenital adrenal hyperplasia in New York State
por: Pearce, Melissa, et al.
Publicado: (2016)

Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant
por: Balsamo, Antonio, et al.
Publicado: (2020)

Real-World Estimates of Adrenal Insufficiency–Related Adverse Events in Children With Congenital Adrenal Hyperplasia
por: Ali, Salma R, et al.
Publicado: (2020)

SUN-212 Interference in Serum Androstenedione Measured by LC-MS/MS in Newborns Samples
por: Lima-Valassi, Helena Panteliou, et al.
Publicado: (2020)

Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States
por: Edelman, Sari, et al.
Publicado: (2020)

Wisconsin’s Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia
por: Bialk, Eric R., et al.
Publicado: (2019)

Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia
por: Navardauskaitė, Rūta, et al.
Publicado: (2021)

Massive adrenal incidentalomas and late diagnosis of congenital adrenal hyperplasia in prostate cancer
por: Feng, Xin, et al.
Publicado: (2017)

Moderate congenital adrenal hyperplasia in two girls diagnosed by newborn screening
por: Banaszak-Ziemska, Magdalena, et al.
Publicado: (2021)

Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry
por: Lawrence, Neil, et al.
Publicado: (2022)

Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand
por: de Hora, Mark R., et al.
Publicado: (2022)

Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia
por: Righi, Beatrice, et al.
Publicado: (2023)

Congenital adrenal hyperplasia
por: Dessinioti, Cleo, et al.
Publicado: (2009)

Congenital Adrenal Hyperplasia
por: Speiser, Phyllis W.
Publicado: (2015)

Brain White Matter Abnormality in a Newborn Infant with Congenital Adrenal Hyperplasia
por: Kaga, Akimune, et al.
Publicado: (2013)

Results from 28 Years of Newborn Screening for Congenital Adrenal Hyperplasia in Sapporo
por: Morikawa, Shuntaro, et al.
Publicado: (2014)

Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
por: Held, Patrice K., et al.
Publicado: (2020)

Challenges in Assessing the Cost-Effectiveness of Newborn Screening: The Example of Congenital Adrenal Hyperplasia
por: Grosse, Scott D., et al.
Publicado: (2020)

Bone Mineral Density in Children and Adolescents with Congenital Adrenal Hyperplasia
por: Garcia Alves Junior, Paulo Alonso, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ok8l1utp6uaal9mo99ag81poed